Cohance Lifesciences Limited

₹442.00As of Sun 8 Nov 2026, 12:00 UTC
NSE:COHANCEHealthcare
Country India
PE (Fwd) •••
TSR 7Y CAGR 25.62%
Div yield —
ROE (0.14%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.59
PE TTM 359.5
TSR TTM (41.33%)
Mkt cap ₹169.1B
ROIC (0.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹440
(0.39%)
246.17%
Hold 0|3|5|8|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
5.68
5.59
5.68
6.25
12.69%
10.42%
7.01%
12.51%
Revenue₹B
8.999
8.755
9.246
9.615
0.56%
(4.23%)
2.68%
9.07%
Peers (US$1.764B)
Cap (US$)
PE
1.827B
24.12x
1.713B
90.31x
1.686B
12.63x
1.766B
9.215x
Capital
TTM
5Y
10Y
Leveragex
0.874
3.250
2.392
EBIT/Intx
0.320
0.131
0.119
Own earn%
15.80
5.11
4.23
Sh yield%
14.21
41.64
41.50
Owners
Insiders/Inst%
13.47
35.84
Short interest%
0.89
SBC / revenue%
4.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
0–5
$1 testx
0.4
Incr. ROIC%
4